PRASX Performance — T. Rowe Price New Asia Fund
Data updated: 2026-09-25
PRASX returned +18.95% year to date and +34.33% over one year to Jul 2026. Annualised returns are +15.17% over 3 years and +4.06% over 5 years. Against its Asia-Pacific Equity category average the fund came out behind over three years but ahead over one: $100 invested three years ago grew to $153, against $164 for the category, and to $134 over one year, against $134. Volatility over the past three years was 17.57% a year. In the 12 months to Jul 2026 the fund lost a net $58.0M, and assets reached $2.51B.
PRASX Growth of $100
What $100 invested in T. Rowe Price New Asia Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Asia-Pacific Equity category average over the same months.
| Period | PRASX | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $134 | $134 |
| 3 years (Aug 2023 – Jul 2026) | $153 | $164 |
| 5 years (Aug 2021 – Jul 2026) | $122 | $142 |
| Since data start (Aug 2019 – Jul 2026) | $175 | $194 |
PRASX Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +18.95% |
| 1 year | +34.33% |
| 3 years (annualised) | +15.17% |
| 5 years (annualised) | +4.06% |
PRASX Annual Returns
Calendar-year total returns of T. Rowe Price New Asia Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +18.95% |
| 2025 | +26.63% |
| 2024 | +6.97% |
| 2023 | +0.80% |
| 2022 | −22.60% |
| 2021 | −4.30% |
| 2020 | +29.57% |
| 2019 (Aug–Dec) | +12.37% |
PRASX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +6.3% | +5.9% | −11.3% | +14.5% | +9.9% | +2.1% | −7.3% | — | — | — | — | — |
| 2025 | +0.2% | +1.8% | −0.3% | −0.9% | +4.0% | +5.0% | +1.9% | +3.1% | +6.1% | +3.2% | −2.8% | +2.9% |
| 2024 | −6.0% | +5.7% | +1.4% | +0.2% | +1.8% | +4.4% | +0.1% | +0.8% | +5.9% | −4.2% | −1.7% | −0.8% |
| 2023 | +10.9% | −7.0% | +3.0% | −3.6% | −3.0% | +2.8% | +4.1% | −7.1% | −3.7% | −3.3% | +6.3% | +3.1% |
| 2022 | −1.8% | −4.9% | −7.2% | −6.8% | +2.2% | −1.1% | −1.1% | −2.1% | −12.0% | −5.8% | +20.4% | −1.9% |
| 2021 | +4.1% | +1.5% | −0.7% | +1.2% | +0.5% | −0.5% | −7.1% | +2.1% | −3.4% | +1.6% | −4.1% | +1.0% |
| 2020 | −5.0% | +0.4% | −12.9% | +9.2% | +1.1% | +9.1% | +7.8% | +3.8% | −1.1% | +2.3% | +7.6% | +6.3% |
| 2019 | — | — | — | — | — | — | — | −2.2% | +3.2% | +4.4% | +0.5% | +6.2% |
PRASX Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 17.57%
- 3-year Sharpe ratio: 0.61 (vs 4.5% risk-free rate)
- Best month: +14.50% (Apr 2026)
- Worst month: −11.26% (Mar 2026)
PRASX Fund Flows
Monthly money in and out of T. Rowe Price New Asia Fund, from SEC Form N-PORT.
- 12-month net flow: −$58.0M
- 12-month gross sales (incl. reinvestments): $530.7M
- Sales ÷ redemptions: 0.90×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $13.3M | $63.8M | −$50.5M |
| Jun 2026 | $54.8M | $93.7M | −$38.9M |
| May 2026 | $136.8M | $61.4M | $75.5M |
| Apr 2026 | $77.2M | $25.4M | $51.7M |
| Mar 2026 | $7.2M | $28.0M | −$20.8M |
| Feb 2026 | $36.9M | $150.3M | −$113.4M |
| Jan 2026 | $21.3M | $29.4M | −$8.1M |
| Dec 2025 | $26.0M | $25.4M | $579K |
| Nov 2025 | $137.8M | $43.0M | $94.8M |
| Oct 2025 | $9.3M | $24.5M | −$15.3M |
| Sep 2025 | $4.1M | $20.8M | −$16.7M |
| Aug 2025 | $6.1M | $23.1M | −$17.0M |
PRASX Assets Under Management
Net assets of T. Rowe Price New Asia Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $2.51B |
| 2026-04-30 | $2.42B |
| 2026-01-31 | $2.32B |
| 2025-10-31 | $2.11B |
| 2025-07-31 | $1.92B |
| 2025-04-30 | $1.77B |
| 2025-01-31 | $1.82B |
| 2024-10-31 | $1.98B |
| 2024-07-31 | $2.00B |
| 2024-04-30 | $1.95B |
| 2024-01-31 | $1.90B |
| 2023-10-31 | $2.18B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.